Combating the rising tide of multi-resistant superbugs
Our Mission is to develop and commercialise the worldwide use of CarboHydrate Derived Fulvic Acid (CHD-FA) in Human and Animal Healthcare.
Re-usable evidence such as the proven safety and toxicity data means that CHD-FA can provide the platform technology for a wide range of applications at vastly reduced timeframes and cost.
We plan to launch a range of ‘application’ companies in various sectors with a view to developing these value propositions in order to
Fulhold is currently seeking U.S. and EU Regulatory approvals for both the active ingredient itself and also formulated products for an initial set of applications such as
Our intention is to seek funding in order to accelerate this plan. The funding would be used, for example, to